文献速递免疫规划

靶向福氏志贺菌6型的志贺菌结合疫苗可诱导免疫并抵御强毒攻击

Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.
PubMed 文献 · Vaccine · 2024-08-31

研究开发了靶向福氏志贺菌6型的志贺菌结合疫苗(SCV-Sf6),采用方酸化学偶联平台和载体蛋白rTTHc。该疫苗可被血清型特异性单克隆抗体及孟加拉国志贺菌病患者恢复期血清识别,在小鼠中诱导血清型特异性OSP和LPS的IgG、IgM反应及rTTHc特异性IgG反应,磷酸铝佐剂可增强免疫反应,并诱导杀菌抗体、保护小鼠抵抗致死性强毒攻击。

要点

  • SCV-Sf6采用方酸化学偶联平台和载体蛋白rTTHc制备,可被血清型特异性单克隆抗体和恢复期血清识别。
  • 小鼠接种SCV-Sf6可诱导血清型特异性OSP和LPS的IgG、IgM反应及rTTHc特异性IgG反应。
  • 磷酸铝佐剂可增强免疫反应,接种小鼠产生杀菌抗体并抵抗致死性福氏志贺菌6型攻击。

核心结论

  • SCV-Sf6可诱导血清型特异性免疫应答和杀菌抗体,并保护小鼠抵抗致死性福氏志贺菌6型攻击,有助于多价志贺菌疫苗的开发。

研究设计与样本

  • 临床前研究:采用方酸化学偶联平台和载体蛋白rTTHc制备靶向福氏志贺菌6型的志贺菌结合疫苗(SCV-Sf6),并进行小鼠免疫原性和攻毒保护实验。

主要发现

  • SCV-Sf6可被血清型特异性单克隆抗体及孟加拉国志贺菌病患者恢复期血清识别,提示OSP免疫展示正确。
  • 小鼠接种SCV-Sf6后诱导血清型特异性OSP和LPS的IgG、IgM反应以及rTTHc特异性IgG反应。
  • 与磷酸铝佐剂共同给药时免疫反应增强。
  • 接种诱导针对福氏志贺菌6型的杀菌抗体反应,接种动物抵抗致死性福氏志贺菌6型强毒攻击。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunity protective against shigella infection targets the bacterial O-specific polysaccharide (OSP) component of lipopolysaccharide. A multivalent shigella vaccine would ideally target the most common global Shigella species and serotypes such as Shigella flexneri 2a, S. flexneri 3a, S. flexneri 6, and S. sonnei. We previously reported development of shigella conjugate vaccines (SCVs) targeting S. flexneri 2a (SCV-Sf2a) and 3a (SCV-Sf3a) using a platform squaric acid chemistry conjugation approach and carrier protein rTTHc, a 52 kDa recombinant protein fragment of the heavy chain of tetanus toxoid. Here we report development of a SCV targeting S. flexneri 6 (SCV-Sf6) using the same platform approach. We demonstrated that SCV-Sf6 was recognized by serotype-specific monoclonal antibodies and convalescent sera of humans recovering from shigellosis in Bangladesh, suggesting correct immunological display of OSP. We vaccinated mice and found induction of serotype-specific OSP and LPS IgG and IgM responses, as well as rTTHc-specific IgG responses. Immune responses were increased when administered with aluminum phosphate adjuvant. Vaccination induced bactericidal antibody responses against S. flexneri 6, and vaccinated animals were protected against lethal challenge with virulent S. flexneri 6. Our results assist in the development of a multivalent vaccine protective against shigellosis.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kelly M, Janardhanan J, Wagh C, et al. Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge. Vaccine. 2024. PMID: 39217775. doi:10.1016/j.vaccine.2024.126263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。